Citations

Mayo Clinic

Clear

1 citation(s) found for "Upadhyay, Navneet".

Cost per remission for mirikizumab versus ustekinumab for moderately to severely active ulcerative colitis treatment from the United States commercial payer perspective
Gulati, Ankit, Kane, Sunanda V. , Creveling, Thomas, Bires, Nicholas, Fisher, Deborah A. , Chanan, Neha, Koushik, Amit Kumar, Upadhyay, Navneet , Gulati, Ankit, Mittal, Neha

Journal of Medical Economics | May 12, 2025 | Volume: 28 | Issue: 1 | Pages: 709-718

10.1080/13696998.2025.2503661 | PMID 40351121 Get It